Results 101 to 110 of about 1,160,625 (318)
Letter to the Editor regarding the article “Radical prostatectomy after previous transurethral resection of the prostate: oncological, surgical and functional outcomes—a meta-analysis” [PDF]
Peihua Liu, Yangle Li
openalex +1 more source
Drosophila park mutants serve as a model for Parkinson's disease. We used this strain to investigate the connection between oxidative stress and the circadian clock mechanism. We showed that increased oxidative stress affects the physiology of pacemaker cells, disrupting their daily structural plasticity. Lack of rhythmic signaling from pacemaker cells
Kamila Zientara +3 more
wiley +1 more source
IntroductionFunctional outcomes following stroke thrombectomy are commonly measured by the modified Rankin Scale (mRS). Due to hemisphere-specific representation of neuropsychological function, the mRS might underestimate persisting functional deficits ...
Hannah Hild +3 more
doaj +1 more source
Is PHILOS as good as it sounds to be? Analysis of complications and functional outcome of PHILOS plating [PDF]
Khadabadi NA, Shivappa K. Saidapur
openalex +1 more source
Structural insights and therapeutic targets in Acinetobacter baumannii capsule biosynthesis
Hypervirulent KL49 A. baumannii's capsular polysaccharide contains the nonulosonic acid 8‐epi‐Leg5,7Ac2, synthesized by epimerization via ElaA, ElaB, and ElaC. Crystal structures of ElaA, ElaB, and ElaC reveal their role in CMP‐Leg5,7Ac2 synthesis and regioselective C8 epimerization.
Woo Cheol Lee +7 more
wiley +1 more source
Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model [PDF]
Caryn Hampton +13 more
openalex +1 more source
Functional outcome of operative vs conservative management of 4 part proximal humerus fracture: A prospective comparative study [PDF]
Manjunath S Japatti +2 more
openalex +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Nicholas Birkett,1 Karam Al-Tawil,1 Alexander Montgomery2 1Princess Alexandra Hospital, Harlow, Essex CM20 1QX, UK; 2Royal London Hospital, London E1 1FR, UKCorrespondence: Nicholas BirkettPrincess Alexandra Hospital, Hamstel Road, Harlow, Essex CM20 1QX,
Birkett N, Al-Tawil K, Montgomery A
doaj

